Jiangsu Hengrui Pharmaceuticals Co., Ltd.SSE: 600276

(600276)"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Indicative Announcement on Acceptance of Application for Drug Marketing Authorization and Inclusion in the Priority Review Program

· Issued by Jiangsu Hengrui Pharmaceuticals Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 600276 ·

On 6ix: 6ix.com/news/600276jiangsu-hengrui-pharmaceuticals-co-ltdindicative-announcement-on-acceptance-of-application-for-drug-marketing-authorization-and-inclusion-in-the-priority-review-program

Indicative Announcement on Acceptance of Application for Drug Marketing Authorization and Inclusion in the Priority Review Program

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix is reading this filing.

View original source (Shanghai Stock Exchange)Jiangsu Hengrui Pharmaceuticals Co., Ltd. on 6ix

Story so far

Earlier from Jiangsu Hengrui Pharmaceuticals

All Jiangsu Hengrui Pharmaceuticals news releases